Crossmark

Clinical outcomes of tocilizumab therapy in polyarticular and systemic juvenile idiopathic arthritis: a single-center analysis (2018-2022)

Crossref DOI link: https://doi.org/10.1007/s00296-024-05711-4

Published Online: 2024-09-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gazda, Agnieszka https://orcid.org/0000-0002-3771-9356
Naishtetik, Iryna https://orcid.org/0000-0002-8293-7993
Kołodziejczyk, Beata

Rybak, Khrystyna https://orcid.org/0009-0004-9665-0338
Mańczak, Małgorzata https://orcid.org/0000-0002-0736-0389
Wójtowicz, Joanna

Krasowicz-Towalska, Olga https://orcid.org/0009-0009-6853-8564
Gietka, Piotr https://orcid.org/0000-0002-2413-0083
License Information

Text and Data Mining valid from 2024-09-23

Version of Record valid from 2024-09-23
More Information

Article History

Received: 19 April 2024

Accepted: 14 August 2024

First Online: 23 September 2024